|
Re: In the near term we will continue our multi-point approach to progressing our corporate commercial value. This approach involves aggressive explorator
|
5
|
Resverlogix Corp.
|
Dec 06, 2019 08:54AM
|
|
Re: Thanks BDAZ
|
5
|
Resverlogix Corp.
|
Sep 26, 2019 09:17AM
|
|
About Makalu Fund
|
5
|
Resverlogix Corp.
|
Nov 02, 2018 10:37AM
|
|
I am hoping...
|
5
|
Resverlogix Corp.
|
Oct 09, 2019 12:00PM
|
|
Re: Hmmm....
|
5
|
Resverlogix Corp.
|
May 02, 2019 10:40AM
|
|
Re: New MD&A posted
|
5
|
Resverlogix Corp.
|
Dec 17, 2019 08:26AM
|
|
Re: Question...glimmers of hope?
|
5
|
Resverlogix Corp.
|
Sep 30, 2019 03:11PM
|
|
Re: Can someone tell me why this news today is not NR worthy?
|
5
|
Resverlogix Corp.
|
Dec 06, 2019 09:51AM
|
|
Re: RVX AGM Q&A, post AGM-huddle, impressions
|
5
|
Resverlogix Corp.
|
Sep 19, 2018 08:47AM
|
|
Epigenetics article,...
|
5
|
Resverlogix Corp.
|
Jun 03, 2019 03:06PM
|
|
Re: Clicks refresh on the PPS....WoW!!!
|
5
|
Resverlogix Corp.
|
Dec 19, 2019 03:21PM
|
|
Re: Peter Libby / You Tube Interview
|
5
|
Resverlogix Corp.
|
Aug 16, 2019 09:14AM
|
|
Playing with Number of patient years and RRR%
|
5
|
Resverlogix Corp.
|
Apr 01, 2019 10:05AM
|
|
Re: Just back from IR,...
|
5
|
Resverlogix Corp.
|
Oct 25, 2019 09:18PM
|
|
Re: NIH Halts Large Cardiovascular Inflammation Reduction Trial (CIRT)
|
5
|
Resverlogix Corp.
|
Sep 25, 2018 10:10AM
|
|
Re: Updated Van Leeuwenhoeck Analyst Report by Marcel Wijma 5/2/2019
|
5
|
Resverlogix Corp.
|
May 02, 2019 11:53PM
|
|
We must be careful also...
|
5
|
Resverlogix Corp.
|
Nov 20, 2019 10:54AM
|
|
Re: Updated Van Leeuwenhoeck Analyst Report by Marcel Wijma 5/2/2019
|
5
|
Resverlogix Corp.
|
May 03, 2019 06:37AM
|
|
Re: What if
|
5
|
Resverlogix Corp.
|
Mar 06, 2019 10:44AM
|
|
I'm gonna go out on a limb,...
|
5
|
Resverlogix Corp.
|
Nov 11, 2019 10:16AM
|
